AKAM vs BRTX · P/E 27, rev $2.17B vs rev $359.7K
Akamai Technologies Inc (AKAM) versus BioRestorative Therapies Inc (BRTX) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported BRTX revenue for 2025-12-31 was $359.7K. Net income was -$14.2M. Revenue was down 10.3% from 2024-12-31 to 2025-12-31. BRTX currently screens at market cap $10.2M.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. BRTX currently screens at market cap $10.2M.
Not investment advice. Open the AKAM and BRTX stock pages for the full models.
Not investment advice.